PPARα: A potential therapeutic target of cholestasis
The accumulation of bile acids in the liver leads to the development of cholestasis and hepatocyte injury. Nuclear receptors control the synthesis and transport of bile acids in the liver. Among them, the farnesoid X receptor (FXR) is the most common receptor studied in treating cholestasis. The act...
Saved in:
Main Authors: | Xiaoyin Ye (Author), Tong Zhang (Author), Han Han (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The potential of natural products for targeting PPARα
by: Daniela Rigano, et al.
Published: (2017) -
Therapeutic potential of PPARα agonist in ligature-induced experimental periodontitis
by: Ying Chen, et al.
Published: (2022) -
Salidroside may target PPARα to exert preventive and therapeutic activities on NASH
by: Xueru Chu, et al.
Published: (2024) -
Emerging Therapeutic Role of PPAR-α in Cognition and Emotions
by: Khalin E. Nisbett, et al.
Published: (2018) -
Da-Chai-Hu-Tang Protects From Acute Intrahepatic Cholestasis by Inhibiting Hepatic Inflammation and Bile Accumulation via Activation of PPARα
by: Shihao Xu, et al.
Published: (2022)